As American life sciences companies increasingly diversify away from China, Indian firms report a surge in interest, investment, and strategic partnerships. "Everybody... they all have China-free strategy," said Vivek Sharma chairman of an Indian producer. One public company from India recently told investors, "There is a continuing pipeline build of...